Devices for transcatheter mitral valve repair: current technology and a glimpse into the future

References

• Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–1011.
   PubMed Web of Science ®Google Scholar
• Iung B, Baron G, Tornos P, et al. Valvular heart disease in the community: a European experience. Curr Probl Cardiol. 2007;32(11):609–661.
   PubMed Web of Science ®Google Scholar
• D’Arcy JL, Coffey S, Loudon MA, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE population cohort study. Eur Heart J. 2016;37(47):3515–3522.
   PubMed Web of Science ®Google Scholar
• Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018;391(10124):960–969.
   PubMed Web of Science ®Google Scholar
• * Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2020;77(4):e25–e97.
   Web of Science ®Google Scholar
• ** Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2786.
   Google Scholar
• * El Sabbagh A, Reddy YNV, Nishimura RA. Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions. JACC Cardiovasc Imaging. 2018;11(4):628–643
   Google Scholar
• Carpentier A. Cardiac valve surgery: the “French correction. J Thorac Cardiovasc Surg. 1983;86(3):323–337.
   PubMed Web of Science ®Google Scholar
• Delahaye JP, Gare JP, Viguier E, et al. Natural history of severe mitral regurgitation. Eur Heart J. 1991;12(suppl B):5–9.
   PubMedGoogle Scholar
• * Dziadzko V, Dziadzko M, Medina-Inojosa JR, et al. Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome. Eur Heart J. 2019;40(27):2194–2202
   Google Scholar
• Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011;8(3):162–172.
   PubMed Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. J Am Coll Cardiol. 2020;76:2982–3021.
   PubMed Web of Science ®Google Scholar
• Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J. 2010;31(16):1958–1967.
   PubMed Web of Science ®Google Scholar
• Lim DS, Reynolds MR, Feldman T, et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol. 2014;64(2):182–192.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Rankin JS, Gammie JS, et al. Isolated mitral valve surgery risk in 77,836 patients from the society of thoracic surgeons database. Ann Thorac Surg. 2013;96(5):1587–1595.
   PubMed Web of Science ®Google Scholar
• Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, A prospective, multicenter, nonrandomized post-approval study of the Mitraclip therapy in Europe. J Am Coll Cardiol. 2013;62(12):1052–1061.
   PubMed Web of Science ®Google Scholar
• Taramasso M, Maisano F, Denti P, et al. Percutaneous edge-to-edge repair in high-risk and elderly patients with degenerative mitral regurgitation: midterm outcomes in a single-center experience. J Thorac Cardiovasc Surg. 2014;148(6):2743–2750.
   PubMed Web of Science ®Google Scholar
• Swaans MJ, Bakker ALM, Alipour A, et al. Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients. JACC Cardiovasc Interv. 2014;7(8):875–881.
   PubMed Web of Science ®Google Scholar
• *Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66(25):2844–2854.
   PubMed Web of Science ®Google Scholar
• Samad Z, Shaw LK, Phelan M, et al. Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. Eur Heart J. 2015;36(40):2733–2741.
   PubMed Web of Science ®Google Scholar
• Rossi A, Dini FL, Faggiano P, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011;97(20):1675–1680.
   PubMed Web of Science ®Google Scholar
• Grigioni F, Enriquez-Sarano M, Zehr KJ, et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103(13):1759–1764.
   PubMed Web of Science ®Google Scholar
• Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol. 2011;58(14):1474–1481.
   PubMed Web of Science ®Google Scholar
• Marsit O, Clavel MA, Côté-Laroche C, et al. Attenuated mitral leaflet enlargement contributes to functional mitral regurgitation after myocardial infarction. J Am Coll Cardiol. 2020;75(4):395–405.
   PubMed Web of Science ®Google Scholar
• Michler RE, Smith PK, Parides MK, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374(20):1932–1941.
   PubMed Web of Science ®Google Scholar
• Kopjar T, Gasparovic H, Mestres CA, et al. Meta-analysis of concomitant mitral valve repair and coronary artery bypass surgery versus isolated coronary artery bypass surgery in patients with moderate ischaemic mitral regurgitation. Eur J Cardio Thoracic Surg. 2016;50(2):212–222.
   Google Scholar
• Panza JA, Ellis AM, Al-Khalidi HR, et al. Myocardial viability and long-term outcomes in ischemic cardiomyopathy. N Engl J Med. 2019;381(8):739–748.
   PubMed Web of Science ®Google Scholar
• Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374(4):344–353.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Foster E, Bourgoun M, et al. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation. 2010;122(10):985–992.
   PubMed Web of Science ®Google Scholar
• Kang DH, Park SJ, Shin SH, et al. Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation: PRIME study. Circulation. 2019;139(11):1354–1365.
   PubMed Web of Science ®Google Scholar
• Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385–1390.
   PubMed Web of Science ®Google Scholar
• Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of mitraclip for this unmet need. J Am Coll Cardiol. 2014;63(2):185–186.
   PubMed Web of Science ®Google Scholar
• Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28(11):1358–1365.
   PubMed Web of Science ®Google Scholar
• Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379(24):2307–2318.
   PubMed Web of Science ®Google Scholar
• Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardio Thoracic Surg. 1998. DOI:10.1016/S1010-7940(98)00014-1.
   PubMed Web of Science ®Google Scholar
• Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the mitraclip system. safety and midterm durability in the initial EVEREST (endovascular valve edge-to-edge repair study) cohort. J Am Coll Cardiol. 2009;54(8):686–694.
   PubMed Web of Science ®Google Scholar
• Chakravarty T, Makar M, Patel D, et al. Transcatheter edge-to-edge mitral valve repair with the mitraclip G4 system. JACC Cardiovasc Interv. 2020;13(20):2402–2414.
   PubMed Web of Science ®Google Scholar
• Kuwata S, Taramasso M, Czopak A, et al. Continuous direct left atrial pressure: intraprocedural measurement predicts clinical response following mitraclip therapy. JACC Cardiovasc Interv. 2019;12(2):127–136.
   PubMed Web of Science ®Google Scholar
• Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (endovascular valve edge-to-edge repair) high risk study. J Am Coll Cardiol. 2012;59(2):130–139.
   PubMed Web of Science ®Google Scholar
• Puls M, Lubos E, Boekstegers P, et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. 2016;37(8):703–712.
   PubMed Web of Science ®Google Scholar
• Sorajja P, Vemulapalli S, Feldman T, et al. Outcomes with transcatheter mitral valve repair in the United States: an STS/ACC TVT registry report. J Am Coll Cardiol. 2017;70(19):2315–2327.
   PubMed Web of Science ®Google Scholar
• Obadia J-F, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379(24):2297–2306.
   PubMed Web of Science ®Google Scholar
• Praz F, Braun D, Unterhuber M, et al. Edge-to-edge mitral valve repair with extended clip arms: early experience from a multicenter observational study. JACC Cardiovasc Interv. 2019;12(14):1356–1365.
   PubMed Web of Science ®Google Scholar
• Kar S, Rottbauer W, Mahoney P. Core- lab adjudicated contemporary clinical outcomes at 1 year with MitraClipTM (NTR/XTR) system from global EXPAND study [Internet]. Cardiovascular Research Foundation; 2020 [cited 2021 Mar 30]. Available from: https://www.tctmd.com/slide/core-lab-adjudicated-contemporary-clinical-outcomes-1-year-mitracliptm-ntrxtr-system-global
   Google Scholar
• Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging. 2019;12(2):353–362.
   PubMed Web of Science ®Google Scholar
• Adamo M, Cani DS, Gavazzoni M, et al. Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair. EuroIntervention. 2020;16(5):413–420.
   Web of Science ®Google Scholar
• Adamo M, Fiorelli F, Melica B, et al. COAPT-like profile predicts long-term outcomes in patients with secondary mitral regurgitation undergoing mitraclip implantation. JACC Cardiovasc Interv. 2021;14(1):15–25.
   PubMedGoogle Scholar
• Iung B, Armoiry X, Vahanian A, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years. Eur J Heart Fail. 2019;21(12):1619–1627.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Lindenfeld JA, Abraham WT, et al. 3-Year outcomes of transcatheter mitral valve repair in patients with heart failure. J Am Coll Cardiol. 2021;77(8):1029–1040.
   PubMed Web of Science ®Google Scholar
• Godino C, Munafò A, Scotti A, et al. MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the international mitrabridge registry. J Heart Lung Transplant. 2020;39(12):1353–1362.
   PubMed Web of Science ®Google Scholar
• Falasconi G, Pannone L, Melillo F, et al. Use of MitraClip system for severe mitral regurgitation in cardiogenic shock: results from a multicentre observational Italian experience (the MITRA-SHOCK study). Eur Heart J. 2020;41(Supplement_2):2635.
   Google Scholar
• Jung RG, Simard T, Kovach C, et al. Transcatheter mitral valve repair in cardiogenic shock and mitral regurgitation: a patient-level, multicenter analysis. JACC Cardiovasc Interv. 2021;14(1):1–11.
   PubMedGoogle Scholar
• Boekstegers P, Hausleiter J, Baldus S, et al. Percutaneous interventional mitral regurgitation treatment using the mitra-clip system. Clin Res Cardiol. 2014;103(2):85–96.
   PubMed Web of Science ®Google Scholar
• Lesevic H, Karl M, Braun D, et al. Long-term outcomes after mitraclip implantation according to the presence or absence of EVEREST inclusion criteria. Am J Cardiol. 2017;119(8):1255–1261.
   PubMed Web of Science ®Google Scholar
• Mauri V, Besler C, Riebisch M, et al. German multicenter experience with a new leaflet-based transcatheter mitral valve repair system for mitral regurgitation. JACC Cardiovasc Interv. 2020;13(23):2769–2778.
   PubMed Web of Science ®Google Scholar
• Lim DS, Kar S, Spargias K, et al. Transcatheter valve repair for patients with mitral regurgitation. JACC Cardiovasc Interv. 2019;12(14):1369–1378.
   PubMed Web of Science ®Google Scholar
• Webb JG, Hensey M, Szerlip M, et al. 1-Year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study. JACC Cardiovasc Interv. 2020;13(20):2344–2357.
   PubMed Web of Science ®Google Scholar
• Maisano F, Vanermen H, Seeburger J, et al. Direct access transcatheter mitral annuloplasty with a sutureless and adjustable device: preclinical experience. Eur J Cardio Thoracic Surg. 2012;42(3):524–529.
   PubMed Web of Science ®Google Scholar
• Maisano F, La Canna G, Latib A, et al. First-in-man transseptal implantation of a surgical-like mitral valve annuloplasty device for functional mitral regurgitation. JACC Cardiovasc Interv. 2014;7(11):1326–1328.
   PubMed Web of Science ®Google Scholar
• Maisano F, Taramasso M, Nickenig G, et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J. 2016;37(10):817–825.
   PubMed Web of Science ®Google Scholar
• Maisano F, Taramasso M, Guidotti A, et al. The cardioband: strategies for optimal patient selection and optimised results. EuroIntervention. 2016;12(Y):Y61–Y63.
   PubMedGoogle Scholar
• Nickenig G, Hammerstingl C, Schueler R, et al. Transcatheter mitral annuloplasty in chronic functional mitral regurgitation: 6-month results with the cardioband percutaneous mitral repair system. JACC Cardiovasc Interv. 2016;9(19):2039–2047.
   PubMed Web of Science ®Google Scholar
• Messika-Zeitoun D, Nickenig G, Latib A, et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. Eur Heart J. 2019;40(5):466–472.
   PubMed Web of Science ®Google Scholar
• Weber M, Öztürk C, Taramasso M, et al. Leaflet edge-to-edge treatment versus direct annuloplasty in patients with functional mitral regurgitation. EuroIntervention. 2019;15(10):912–918.
   PubMed Web of Science ®Google Scholar
• Braun D, Näbauer M, Massberg S, et al. One-stop shop: simultaneous direct mitral annuloplasty and percutaneous mitral edge-to-edge repair in a patient with severe mitral regurgitation. Catheter Cardiovasc Interv. 2019;93(5):E318–E319.
   PubMed Web of Science ®Google Scholar
• Mangieri A, Colombo A, Demir OM, et al. Percutaneous direct annuloplasty with edge-to-edge technique for mitral regurgitation: replicating a complete surgical mitral repair in a one-step procedure. Can J Cardiol. 2018;34(8):1088.e1–1088.e2.
   PubMed Web of Science ®Google Scholar
• Götz N, Schreieck J, Langer HF, et al. Treatment of a patient with primary mitral regurgitation using the Cardioband® system. Eur Heart J. 2019;3:1–3.
   Web of Science ®Google Scholar
• Rogers JH, Boyd WD, Smith TW, et al. Early experience with Millipede IRIS transcatheter mitral annuloplasty. Ann Cardiothorac Surg. 2018;7(6):780–786.
   PubMed Web of Science ®Google Scholar
• Rogers JH, Boyd WD, Smith TWR, et al. Transcatheter annuloplasty for mitral regurgitation with an adjustable semi-rigid complete ring: initial experience with the millipede IRIS device. Struct Hear. 2018;2(1):43–50.
   Google Scholar
• Rogers JH, Boyd WD, Smith TWR, et al. Combined mitraclip edge-to-edge repair with millipede IRIS mitral annuloplasty. JACC Cardiovasc Interv. 2018;11(3):323–324.
   PubMed Web of Science ®Google Scholar
• Schofer J, Siminiak T, Haude M, et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON mitral annuloplasty device European Union study. Circulation. 2009;120(4):326–333.
   PubMed Web of Science ®Google Scholar
• Maniu CV, Patel JB, Reuter DG, et al. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol. 2004;44:1652–1661.
   PubMed Web of Science ®Google Scholar
• Lipiecki J, Siminiak T, Sievert H, et al. Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial. Open Heart. 2016;3:1–8.
   Web of Science ®Google Scholar
• Maselli D, Guarracino F, Chiaramonti F, et al. Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation. 2006;114(5):377–380.
   PubMed Web of Science ®Google Scholar
• Siminiak T, Wu JC, Haude M, et al. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail. 2012;14(8):931–938.
   PubMed Web of Science ®Google Scholar
• Witte KK, Lipiecki J, Siminiak T, et al. The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation. JACC Hear Fail. 2019;7(11):945–955.
   PubMed Web of Science ®Google Scholar
• Lipiecki J, Kaye DM, Witte KK, et al. Long-term survival following transcatheter mitral valve repair: pooled analysis of prospective trials with the carillon device. Cardiovasc Revascularization Med. 2020;21(6):712–716.
   PubMed Web of Science ®Google Scholar
• Rogers JH, Macoviak JA, Rahdert DA, et al. Percutaneous septal sinus shortening: a novel procedure for the treatment of functional mitral regurgitation. Circulation. 2006;113(19):2329–2334.
   PubMed Web of Science ®Google Scholar
• Palacios IF, Condado JA, Brandi S, et al. Safety and feasibility of acute percutaneous septal sinus shortening: first-in-human experience. Catheter Cardiovasc Interv. 2007;69(4):513–518.
   PubMed Web of Science ®Google Scholar
• Rogers JH, Thomas M, Morice MC, et al. Treatment of heart failure with associated functional mitral regurgitation using the ARTO system initial results of the first-in-human MAVERIC trial (mitral valve repair clinical trial). JACC Cardiovasc Interv. 2015;8(8):1095–1104.
   PubMed Web of Science ®Google Scholar
• Erglis A, Narbute I, Poupineau M, et al. Treatment of secondary mitral regurgitation in chronic heart failure. J Am Coll Cardiol. 2017;70(22):2834–2835.
   PubMed Web of Science ®Google Scholar
• Worthley S, Redwood S, Hildick-Smith D, et al. Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial. EuroIntervention. 2021;16(13):1106–1113.
   Google Scholar
• Savic V, Pozzoli A, Gülmez G, et al. Transcatheter mitral valve chord repair. Ann Cardiothorac Surg. 2018;7(6):731–740.
   PubMed Web of Science ®Google Scholar
• Seeburger J, Borger MA, Tschernich H, et al. Transapical beating heart mitral valve repair. Circ Cardiovasc Interv. 2010;3(6):611–612.
   PubMed Web of Science ®Google Scholar
• Seeburger J, Leontjev S, Neumuth M, et al. Transapical beating-heart implantation of neo-chordae to mitral valve leaflets: results of an acute animal study. Eur J Cardio Thoracic Surg. 2012;41:173–176.
   PubMed Web of Science ®Google Scholar
• Colli A, Manzan E, Fabio FZ, et al. TEE-guided transapical beating-heart neochord implantation in mitral regurgitation. JACC Cardiovasc Imaging. 2014;7(3):322–323.
   PubMed Web of Science ®Google Scholar
• Colli A, Zucchetta F, Torregrossa G, et al. Transapical off-pump mitral valve repair with neochord implantation (TOP-MINI): step-by-step guide. Ann Cardiothorac Surg. 2015;4(3):295–297.
   PubMed Web of Science ®Google Scholar
• Colli A, Manzan E, Zucchetta F, et al. Feasibility of anterior mitral leaflet flail repair with transapical beating-heart neochord implantation. JACC Cardiovasc Interv. 2014;7(11):1320–1321.
   PubMed Web of Science ®Google Scholar
• Seeburger J, Rinaldi M, Nielsen SL, et al. Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the tact trial (transapical artificial chordae tendinae) proof of concept. J Am Coll Cardiol. 2014;63(9):914–919.
   PubMed Web of Science ®Google Scholar
• Colli A, Manzan E, Rucinskas K, et al. Acute safety and efficacy of the NeoChord procedure. Interact Cardiovasc Thorac Surg. 2015;20(5):575–581.
   PubMed Web of Science ®Google Scholar
• Colli A, Manzan E, Aidietis A, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation. Eur J Cardio Thoracic Surg. 2018;54(3):460–466.
   PubMed Web of Science ®Google Scholar
• Colli A, Manzan E, Besola L, et al. One-year outcomes after transapical echocardiography-guided mitral valve repair. Circulation. 2018;138(8):843–845.
   PubMed Web of Science ®Google Scholar
• Gerosa G, Besola L, Beiras-Fernandez A, et al. The neochord procedure after failed surgical mitral valve repair. Semin Thorac Cardiovasc Surg. 2021;33(1):35–44.
   PubMedGoogle Scholar
• Kiefer P, Meier S, Noack T, et al. Good 5-year durability of transapical beating heart off-pump mitral valve repair with neochordae. Ann Thorac Surg. 2018;106(2):440–445.
   PubMed Web of Science ®Google Scholar
• Gammie JS, Wilson P, Bartus K, et al. Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device. Circulation. 2016;134(3):189–197.
   PubMed Web of Science ®Google Scholar
• Gammie JS, Bartus K, Gackowski A, et al. Beating-heart mitral valve repair using a novel ePTFE cordal implantation device: a prospective trial. J Am Coll Cardiol. 2018;71(1):25–36.
   PubMed Web of Science ®Google Scholar
• Gammie JS, Bartus K, Gackowski A, et al. Safety and performance of a novel transventricular beating heart mitral valve repair system: 1-year outcomes. Eur J Cardio Thoracic Surg. 2021;59:199–206.
   PubMed Web of Science ®Google Scholar
• Chhatriwalla AK, Vemulapalli S, Holmes DR, et al. Institutional experience with transcatheter mitral valve repair and clinical outcomes: insights from the TVT registry. JACC Cardiovasc Interv. 2019;12:1342–1352.
   PubMed Web of Science ®Google Scholar
• Colli A, Manzan E, Zucchetta F, et al. Transapical off-pump mitral valve repair with neochord implantation: early clinical results. Int J Cardiol. 2016;204:23–28.
   PubMed Web of Science ®Google Scholar
• Taramasso M, Gavazzoni M, Nickenig G, et al. Transcatheter mitral repair and replacement: which procedure for which patient? EuroIntervention. 2019;15:867–874.
   PubMed Web of Science ®Google Scholar
• Ristalli F, Meucci F, Stolcova M, et al. MitraClip implantation to treat early recurrence of mitral regurgitation after percutaneous direct annuloplasty with cardioband. JACC Cardiovasc Interv. 2018;11:1416–1417.
   PubMed Web of Science ®Google Scholar
• Brüstle K, Taramasso M, Kuwata S, et al. Transcatheter mitral annuloplasty to treat residual mitral regurgitation after MitraClip implantation. EuroIntervention. 2017;13:912–913.
   PubMed Web of Science ®Google Scholar
• Vassileva CM, McNeely C, Spertus J, et al. Hospital volume, mitral repair rates, and mortality in mitral valve surgery in the elderly: an analysis of US hospitals treating Medicare fee-for-service patients. J Thorac Cardiovasc Surg. 2015;149(3):762–768.
   PubMed Web of Science ®Google Scholar
• Lapar DJ, Ailawadi G, Isbell JM, et al. Mitral valve repair rates correlate with surgeon and institutional experience. J Thorac Cardiovasc Surg. 2014;148:995–1004.
   PubMed Web of Science ®Google Scholar
• Eggebrecht H, Mehta RH, Lubos E, et al. MitraClip in high- versus low-volume centers: an analysis from the German TRAMI registry. JACC Cardiovasc Interv. 2018;11:320–322.
   PubMed Web of Science ®Google Scholar
• Feldman T, Mauri L, Kahwash R, et al. Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF i [reduce elevated left atrial pressure in patients with heart failure]): a phase 2, randomized, sham-controlled trial. Circulation. 2018;137(4):364–375.
   PubMed Web of Science ®Google Scholar
• Schueler R, Öztürk C, Wedekind JA, et al. Persistence of iatrogenic atrial septal defect after interventional mitral valve repair with the mitraclip system: a note of caution. JACC Cardiovasc Interv. 2015;8(3):450–459.
   PubMed Web of Science ®Google Scholar
• Toyama K, Rader F, Kar S, et al. Iatrogenic atrial septal defect after percutaneous mitral valve repair with the mitraclip system. Am J Cardiol. 2018;121(4):475–479.
   PubMed Web of Science ®Google Scholar
• Almalla M, Altiok E, Reith S, et al. Hemodynamic effect of iatrogenic atrial septal defect after percutaneous mitral valve repair using the MitraClip device. Eur Heart J. 2013;34:3590–3590
   PubMed Web of Science ®Google Scholar
• Hoffmann R, Altiok E, Reith S, et al. Functional effect of new atrial septal defect after percutaneous mitral valve repair using the MitraClip device. Am J Cardiol. 2014;113(7):1228–1233
   PubMed Web of Science ®Google Scholar
• Lurz P, Unterhuber M, Rommel KP, et al. Closure of iatrogenic atrial septal defect after transcatheter mitral valve repair: the randomized MITHRAS trial. Circulation. 2021;143:292–294.
   PubMed Web of Science ®Google Scholar
• Praz F, Winkel MG, Fam NP, et al. Age for transcatheter mitral valve repair: the complexity of choice. JACC Cardiovasc Interv. 2020;13:2415–2417.
   PubMed Web of Science ®Google Scholar
• Capodanno D. Trancatheter aortic valve implantation and mitral valve repair: two trains, two speeds. EuroIntervention. 2017;12:1921–1924.
   PubMed Web of Science ®Google Scholar
• Sorajja P, Leon MB, Adams DH, et al. Transcatheter therapy for mitral regurgitation clinical challenges and potential solutions. Circulation. 2017;136:404–417.
   PubMed Web of Science ®Google Scholar
• Colli A, Raanani E, Cobiella J, et al. Transapical and transfemoral combined mitral valve repair with annular and leaflet therapies. Ann Thorac Surg. 2020;110:e221–e223.
   PubMed Web of Science ®Google Scholar
• Von Bardeleben RS, Colli A, Schulz E, et al. First in human transcatheter COMBO mitral valve repair with direct ring annuloplasty and neochord leaflet implantation to treat degenerative mitral regurgitation: feasibility of the simultaneous toolbox concept guided by 3D echo and computed tomography fu. Eur Heart J. 2018;39:1314–1315.
   PubMed Web of Science ®Google Scholar
• Colli A, Beiras-Fernández A, Ruf T, et al. Transcatheter mitral valve repair: single stage combo approach. Rev Española Cardiol. 2019;72:972–975.
   PubMed Web of Science ®Google Scholar
• Maisano F, Taramasso M. Percutaneous mitral valve leaflet repair: ongoing directions and future perspectives. EuroIntervention 2020;16:803–807.
   PubMed Web of Science ®Google Scholar
• Stone GW, Vahanian AS, Adams DH, et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol. 2015;66(3):278–307.
   Google Scholar
• Gad MM, Ahuja KR, Bazarbashi N, et al. The impact of hospital characteristics on the outcomes of interventional cardiac procedures. JACC Cardiovasc Interv. 2019;12:1872–1874.
   PubMed Web of Science ®Google Scholar